NCT06044909 Multimodal Image Registration for Helping Laparoscopic Liver Surgery Guidance
| NCT ID | NCT06044909 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne |
| Condition | Hepatectomy |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2023-09-15 |
| Primary Completion | 2026-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2023-09-15 with a primary completion date of 2026-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Multimodal intraoperative minimal-invasive (laparoscopic or robotic) liver surgery images will be registered to each other. Explicitly, these are the ultrasound and laparoscope images. Once they are registered, they will reveal the hidden tumor's location to the surgeon in real time through augmented reality. The intraoperative augmentation will also be enriched with the preoperative data (e.g., CT or MRI). This will simplify minimal invasive liver surgery, improve surgical safety and accuracy. It will also shorten hospital stays and contribute to an overall better quality of life for the patient, which in return will reduce the health-care costs.
Eligibility Criteria
Inclusion Criteria: * Patients undergoing hepatectomy; * Patients for whom good-quality imaging is available (CT scan and/or MRI and/or ultrasound); * Patients over 18 years of age; * Minimally invasive surgery by conventional or robot-assisted laparoscopy. Exclusion Criteria: * Surgery by laparotomy
Contact & Investigator
Bertrand LE ROY, MD PhD
PRINCIPAL INVESTIGATOR
Centre Hospitalier Universitaire de Saint Etienne
Frequently Asked Questions
Who can join the NCT06044909 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hepatectomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06044909 currently recruiting?
Yes, NCT06044909 is actively recruiting participants. Contact the research team at bertrand.leroy@chu-st-etienne.fr for enrollment information.
Where is the NCT06044909 trial being conducted?
This trial is being conducted at Saint-Etienne, France.
Who is sponsoring the NCT06044909 clinical trial?
NCT06044909 is sponsored by Centre Hospitalier Universitaire de Saint Etienne. The principal investigator is Bertrand LE ROY, MD PhD at Centre Hospitalier Universitaire de Saint Etienne. The trial plans to enroll 40 participants.